Semi-Annual Consolidated Balance Sheet

Oncolys BioPharma Inc. - Filing #7611807

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
3,454,714,000 JPY
2,067,927,000 JPY
Other
12,000 JPY
16,000 JPY
Current assets
4,198,008,000 JPY
2,545,676,000 JPY
Non-current assets
Property, plant and equipment
JPY
21,317,000 JPY
Property, plant and equipment
Intangible assets
Intangible assets
JPY
650,000 JPY
Investments and other assets
93,868,000 JPY
228,769,000 JPY
Investments and other assets
Investment securities
JPY
458,000 JPY
Other
19,000 JPY
19,000 JPY
Non-current assets
93,868,000 JPY
250,736,000 JPY
Assets
4,291,876,000 JPY
2,796,413,000 JPY
Liabilities
Current liabilities
Short-term borrowings
238,880,000 JPY
150,008,000 JPY
Lease liabilities
2,674,000 JPY
2,144,000 JPY
Income taxes payable
59,242,000 JPY
33,486,000 JPY
Current liabilities
430,211,000 JPY
415,244,000 JPY
Non-current liabilities
Long-term borrowings
255,544,000 JPY
366,648,000 JPY
Lease liabilities
6,372,000 JPY
6,275,000 JPY
Non-current liabilities
267,673,000 JPY
377,843,000 JPY
Liabilities
697,884,000 JPY
793,087,000 JPY
Net assets
Share capital
9,039,516,000 JPY
7,436,537,000 JPY
Shareholders' equity
Capital surplus
9,063,645,000 JPY
7,460,666,000 JPY
Retained earnings
-14,516,735,000 JPY
-12,901,296,000 JPY
Treasury shares
-113,000 JPY
-76,000 JPY
Shareholders' equity
3,586,312,000 JPY
1,995,830,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
JPY
-254,000 JPY
Valuation and translation adjustments
JPY
-254,000 JPY
Share acquisition rights
7,680,000 JPY
7,750,000 JPY
Net assets
JPY
7,680,000 JPY
-14,516,735,000 JPY
-113,000 JPY
3,593,992,000 JPY
JPY
9,039,516,000 JPY
-14,516,735,000 JPY
31,740,000 JPY
9,031,904,000 JPY
9,063,645,000 JPY
3,586,312,000 JPY
1,995,830,000 JPY
-12,901,296,000 JPY
2,003,325,000 JPY
7,750,000 JPY
31,740,000 JPY
-254,000 JPY
7,460,666,000 JPY
7,436,537,000 JPY
7,428,925,000 JPY
-254,000 JPY
-12,901,296,000 JPY
-76,000 JPY
7,620,000 JPY
-10,806,209,000 JPY
9,650,000 JPY
7,620,000 JPY
7,121,273,000 JPY
7,940,000 JPY
3,454,048,000 JPY
7,123,423,000 JPY
-10,806,209,000 JPY
3,438,488,000 JPY
7,113,773,000 JPY
JPY
Liabilities and net assets
4,291,876,000 JPY
2,796,413,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.